Alexandra Bowden

Alexandra Bowden is an experienced executive in the biotechnology and pharmaceutical sectors, currently serving as Executive Director at Sana Biotechnology, Inc. since July 2022. Prior positions include Executive Director and Senior Director at Astellas Gene Therapies from May 2019 to October 2022, and Director of Clinical Outcomes Research and Evaluation at Ultragenyx Pharmaceutical Inc. from November 2013 to October 2021. Alexandra has also held roles as Senior Program Manager at BioMarin Pharmaceutical Inc., Manager of Clinical Research and Operations and Scientist at Aerovance Inc., and Research Scientist at Bayer plc UK and Bayer corp. USA. Alexandra holds a PhD in Pharmacology from Imperial College London and a BSc in Pharmacology from the University of Bath.